Tag: Biosimilars
`Rigged’ system blocks use of lower-cost drugs, FDA chief says
WASHINGTON – A “rigged payment scheme” between drug plans, insurers and pharmaceutical companies has blocked access to less-expensive versions of some of the most costly drugs...
Curbing spending on prescription drugs
Millions of patients suffering from painful and chronic medical conditions could find it easier to access effective and more affordable treatment options, as federal...